Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03587662
Title Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center

collecting duct carcinoma

kidney cancer

kidney rhabdoid cancer


Gemcitabine + Ixazomib

Doxorubicin + Gemcitabine + Ixazomib

Age Groups: senior | child | adult
Covered Countries USA

Additional content available in CKB BOOST